Enfortumab vedotin Interactions
There are 446 drugs known to interact with enfortumab vedotin, along with 3 disease interactions. Of the total drug interactions, 73 are major, 329 are moderate, and 44 are minor.
- View all 446 medications that may interact with enfortumab vedotin
- View enfortumab vedotin disease interactions (3)
Most frequently checked interactions
View interaction reports for enfortumab vedotin and the medicines listed below.
- Aspir 81 (aspirin)
- Benadryl (diphenhydramine)
- Benefiber Powder (wheat dextrin)
- Bystolic (nebivolol)
- Calcium 600+D Plus Minerals (multivitamin with minerals)
- Colace (docusate)
- CoQ10 (ubiquinone)
- Cymbalta (duloxetine)
- D3 (cholecalciferol)
- Dulcolax Stool Softener (docusate)
- Eliquis (apixaban)
- Farxiga (dapagliflozin)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Lyrica (pregabalin)
- Maxzide (hydrochlorothiazide / triamterene)
- Medrol Dosepak (methylprednisolone)
- Metamucil Orange Smooth Texture Sugar Free (psyllium)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Morphine Sulfate ER (morphine)
- Mucinex (guaifenesin)
- Myrbetriq (mirabegron)
- One Tab Daily (multivitamin)
- OxyContin (oxycodone)
- Protonix (pantoprazole)
- Senokot (senna)
- Tylenol (acetaminophen)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Enfortumab vedotin disease interactions
There are 3 disease interactions with enfortumab vedotin which include:
More about enfortumab vedotin
- enfortumab vedotin consumer information
- Compare alternatives
- Reviews (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.